Co-transfer of human wild-type p53 and granulocyte-macrophage colony-stimulating factor genes via recombinant adenovirus induces apoptosis and enhances immunogenicity in laryngeal cancer cells

Cancer Letters

Volumn 167, Issue 1, 2001, Pages 25-32

  Qiu, Zhao Hua ^a   Lao, Miao Fen ^a   Wu, Chu Tse ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Combination gene therapy; Granulocyte macrophage colony stimulating factor; Laryngeal cancer; p53 tumor suppressor gene; Recombinant adenovirus

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; CYTOTOXICITY; DRUG EFFICACY; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; GENOTOXICITY; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; IN VITRO STUDY; LARYNX CARCINOMA; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR SUPPRESSOR GENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; APOPTOSIS; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, P53; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LARYNGEAL NEOPLASMS; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

EID: 0035838127     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00453-0     Document Type: Article

References (21)

1. Gene therapy for cancer: What have we done and where are we going?
2. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer
3. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus
4. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus
5. The expression of multi-genes via a recombinant adenovirus and their effects of inducing apoptosis on lung cancer cells
6. Inhibition of the growth of pre-established subcutaneous tumor modules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector
7. Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival
8. Parental gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity
9. Molecular staging of head and neck squamous carcinoma
10. Gene-modified tumor cells as a cellular vaccine
11. Cancer vaccines
12. Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic hu-PBL-SCID/Beige mouse-human glioblastoma multiforme model
13. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent specific and long-lasting antitumor immunity
14. Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor
15. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells
16. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
17. Adenovirus as a system for delivering and expressing tumor suppressor genes in tumor cells
18. Activation by the protein-bound polysaccharide psk (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer
19. Induction of autologous tumor-specific cytotoxic T lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD80) costimulation
20. Interleukin-2 gene transduction into freshly isolated lung adenocarcinoma cells with adenoviral vectors
21. Construction of recombinant adenovirus coexpressing human wild-type p53, GM-CSF and B7-1 genes